Stephen Ray Mitchell, Director at Vanda Pharmaceuticals Inc. (VNDA), sold 7,000 shares at $4.59 ($32K) on 2025-06-13, disclosed to the SEC on 2025-06-16.
Seasonal sale ($32k) by Director — this insider has traded VNDA in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| VNDA | SELL | 2022-06-14 | $26K | — | Filing → |
| VNDA | SELL | 2021-09-13 | $640K | — | Filing → |
| VNDA | SELL | 2021-06-17 | $194K | — | Filing → |